Join Growin Stock Community!
Back to PFE.US Analysis
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

ev-to-ebitda-chart

PFE EV/EBITDA

EV/EBITDA

Browsing restrictions can be lifted for a fee.

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

As of Q4'25, Pfizer's (PFE) EV/EBITDA ratio stands at -152.15, marking a dramatic negative shift from previous quarters. This latest data point is a significant deviation from the prior quarter (Q3'25), which recorded a positive value of 12.53. Over the period from Q1'23 to Q4'25, the EV/EBITDA ratio exhibited high volatility, with notable peaks in Q2'24 (94.69) and Q1'24 (48.80), followed by a sharp decline and eventual stabilization around 11–14 in the subsequent quarters. The sudden plunge into negative territory in Q4'25 suggests a substantial deterioration in operating performance or a significant one-time event impacting EBITDA, warranting further investigation into underlying financial drivers during this period.